Branson Pharma AG, is a Swiss pharmaceutical company with a focus on bringing innovative patient treatments across a range of therapeutic categoroes.
BR101 is a bio molecule (packed in a polymer) that demonstrates high efficacy and speed to eliminate a range of infections (endometritis, adenomyosis and endometriosis). Our early tests bring us closer to name this molecule as cure.
Another development, BR201, is a topical treatment/application helping to prevent adhesions post surgery. A product that would not have any analog treatments.
Company Details
- Address
- Zug, Ch
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.bransonpharma.com
- Keywords
- Farmak International Poland.
- HQ
- Zug
Branson Pharma Ag Questions
Branson Pharma Ag's website is http://www.bransonpharma.com
Branson Pharma Ag's LinkedIn profile is https://ch.linkedin.com/company/branson-pharma-ag
Branson Pharma Ag's industry is
Pharmaceutical Manufacturing
Branson Pharma Ag's top competitors are
Sever Pharma Solutions,
Bluepharma,
Insmed Incorporated,
Otifex Therapeutics,
Faes Farma,
Farmak International Poland,
Larive Bio Ag,
Sgi Pharmaceuticals Ag,
Crispr Therapeutics,
Amal Therapeutics.
Branson Pharma Ag's categories are Pharmaceutical Manufacturing
